Linux System Administrator, Invitae
$138.4-173k
Expert genetic insights
Job no longer available
Expert genetic insights
1001+ employees
Job no longer available
$138.4-173k
1001+ employees
Company mission
To bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
Role
Who you are
- 8 years of technical experience with at least 5 years supporting Linux systems demonstrating strong troubleshooting skills, curiosity, and interest in Linux OS configuration and system internals
- Hands-on experience with managing computational and large-scale storage resources in a multi-user environment
- Scripting or programming skills in Bash, Go, Python, or Java in a Linux environment
- Strong desire to identify and mitigate performance bottlenecks
- Preferred: Experience supporting containerized workflows (Singularity/Apptainer, Docker, or Podman) in production and development environments
- Preferred: Experience deploying AWS environments via TerraForm or Cloudformation
- Preferred: Experience with using Salt
What the job involves
- Participate in on-call responses to incidents including crafting fixes or workarounds and improving systems
- Support cluster users with troubleshooting and performance profiling of HPC jobs using systems monitoring and our PostgreSQL HPC job database
- Help configure and maintain our cluster workload manager (Univa/Altair Grid Engine) and cluster nodes to help ensure optimal resource allocation based on organizational needs
- Help maintain our petabytes of on prem state-of-the-art all-flash storage
- Support PIPE Platform colleagues in managing production and development operational services
- Support cluster users with troubleshooting and execution of their Nextflow bioinformatics workflows
- Coordinate with our Networking team for operational support and incident management
- Work with our AWS Operations and EKS teams to stage and test running our PIPE Platform services and bioinformatics workloads in AWS
Otta's take
Xav Kearney
CTO of Otta
Invitae is a medical genetics company that is focused on bringing comprehensive genetic information into mainstream medicine, to improve healthcare for all people at any stage of their life. Its platform is made for providers and patients, with the ability to customize genetic tests in just a few clicks, and flexible pricing that ensures the service is widely accessible.
Despite being lauded for its low selling prices and high testing volume - which makes clinical-grade genetic testing available to the masses - Invitae has received criticism for the way it has been managed. This resulted in a strategic restructuring of the company in 2022, which deprioritised the company's focus on growth, so it could focus on becoming a more sustainable business. In 2024, it listed itself as bankrupt and through a sale, was purchased by Labcorp.
Despite this tumult, Invitae's new home at Labcorp means the company can still extend its platform. Further development of Invitae will be fueled by a range of investments in the form of convertible debt due in 2028 and share exchanges.
Insights
Company
Funding (last 2 of 5 rounds)
Oct 2014
$120m
SERIES F
Dec 2013
$40m
SERIES E
Total funding: $195.5m
Company benefits
- Equity Options
- Comprehensive benefits, including health, dental, and vision
- Generous vacation days ("take all the time you need; don't let your team down") and an excellent family leave policy
- Flexible working hours and opportunities to work from home
Company values
- Team above the individual
- Radically honest communication
- Freedom with accountability
- Transparency and data-informed action
- A sense of urgency
Company HQ
Design District, San Francisco, CA
Founders
Kenneth Knight
(CEO, not founder)Previously worked at Amazon as Vice President, leading Middle Mile operations. Initially served as COO at Invitae, becoming CEO in 2022.
Share this job
View 4 more jobs at Invitae